What are the best over‑the‑counter topical treatments for a fungal infection of the fingernail (onychomycosis)?

Best Over-the-Counter Topical Treatments for Fingernail Onychomycosis

For fingernail fungal infections with limited nail involvement (<80% of nail plate, no lunula involvement), amorolfine 5% nail lacquer applied once weekly for 6 months is the most effective OTC topical option, achieving approximately 50% efficacy in clinical studies. 1

Primary OTC Topical Recommendation

Amorolfine 5% nail lacquer is the preferred first-line OTC topical treatment based on British Association of Dermatologists guidelines: 1

• Apply once or twice weekly (once weekly is equally effective as twice weekly) 1
• Treatment duration: 6 months for fingernails 1
• Before each application, file down as much diseased nail as possible 1
• Achieves approximately 50% clinical cure rate for distal fingernail onychomycosis 1
• Important caveat: Clinical improvement does not equal mycological cure—actual fungal eradication rates are typically 30% lower than clinical appearance suggests 1
• Side effects are minimal: local burning, pruritus, and erythema only 1

Alternative OTC Topical Options (Lower Efficacy)

Ciclopirox 8% lacquer is a second-choice OTC option: 1

• Apply once daily for up to 24 weeks on fingernails 1
• Mycological cure rate of 34% (versus 10% placebo) 1
• Clinical cure rate only 8% (versus 1% placebo) 1
• Cure rates are consistently lower than amorolfine, though no head-to-head trials exist 1
• Side effects: periungual and nail fold erythema 1

Tioconazole 28% solution has poor efficacy: 1

• Only 22% mycological and clinical cure rate 1
• Allergic contact dermatitis is common 1
• Nausea and rashes occur in 8-15% of patients 1
• Not recommended as first-line due to low efficacy and higher side effect profile 1

40% urea ointment is available OTC but functions primarily as a nail softening/removal agent rather than antifungal treatment: 1

• Used to debride diseased nail tissue 1
• Should be combined with actual antifungal therapy 1

Products with Insufficient Evidence

The following OTC products lack adequate clinical data to support their use as monotherapy: 1

• Butenafine 1
• Bifonazole 1
• Salicylic acid 1
• Mentholated ointments 1
• Ozonized sunflower oil 1
• Undecenoates 1

Critical Limitations of OTC Topical Therapy

Topical treatments have inherent barriers to success: 1

• The hard keratin nail plate acts as a barrier—drug concentration drops 1000-fold from outer to inner nail surface 1
• Topical monotherapy is only appropriate for: 1
  • Superficial white onychomycosis (SWO) 1
  • Early distal lateral subungual onychomycosis (DLSO) with <80% nail involvement 1
  • No lunula involvement 1
  • When oral antifungals are contraindicated 1

When OTC Topicals Are Insufficient

Refer for prescription oral therapy if: 1

• More than 80% of nail plate is affected 1
• Lunula is involved 1
• Longitudinal streaks are present 1
• Multiple nails are affected 1
• Patient has diabetes or peripheral vascular disease (higher complication risk) 2

Oral terbinafine remains the gold standard for moderate-to-severe fingernail onychomycosis, with superior efficacy to all topical agents 1

Practical Application Algorithm

1. Confirm diagnosis before starting treatment—clinical appearance alone is insufficient 3
2. Assess extent of involvement: If <80% of nail plate affected and no lunula involvement, topical therapy is appropriate 1
3. First choice: Amorolfine 5% lacquer once weekly for 6 months 1
4. File nail before each application to remove diseased tissue and enhance penetration 1
5. If amorolfine unavailable: Ciclopirox 8% daily for 24 weeks (lower efficacy expected) 1
6. Monitor response: If no improvement after 3 months, consider prescription oral therapy 1

Prevention of Recurrence

Even with successful treatment, recurrence rates are 40-70%: 1

• Keep nails trimmed short 1
• Avoid sharing nail clippers 1
• Consider prophylactic amorolfine application after cure 1
• Address any underlying tinea pedis simultaneously 1